Abstract
Liver transplantation (LT) is the only recognized effective treatment for end-stage liver disease (ESLD) and acute fulminant liver failure [...]
Highlights
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations
The disparity between available liver grafts and waiting list candidates is still elevated and patient mortality whilst awaiting is as high as 10% yearly. In this setting, changing trends in characteristics of patients listed for Liver transplantation (LT) are of great interest as they can impact the decision-making process for recipient selection
In former times, hepatitis C virus (HCV)-related cirrhosis was the main indication for LT
Summary
2 Liver Unit, Queen Elizabeth Hospital Birmingham, Birmingham B15 2TH, UK; v.ronca@bham.ac.uk 3 Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK * Correspondence: aleparen@gmail.com Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Liver transplantation (LT) is the only recognized effective treatment for end-stage liver disease (ESLD) and acute fulminant liver failure.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
